FDA Adverse Event Injury Summary report: N

DYMIC

MDR report key: 20329999 · Received September 29, 2024

Report

Report Number
3009161350-2024-72061
Event Type
Injury
Date Received
September 29, 2024
Date of Event
September 27, 2021
Report Date
September 29, 2024
Manufacturer
PALTOP ADVANCED DENTAL SOLUTIONS INC.
Product Code
DZE
UDI-DI
D76821700060
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
RS
Reporter Occupation
DENTIST
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

FAILURE TO OSSEOINTEGRATE IS A WELL-KNOWN AND INHERENT RISK OF DENTAL IMPLANTS AND IS DOCUMENTED IN THE LITERATURE ACROSS IMPLANT SYSTEMS1, 2 (SEE E.G., KELLER, 1995; BORNSTEIN, 2008,). PALTOP DENTAL SOLUTIONS INC. PROVIDES IFU WITH ALL IMPLANTS. FAILURE TO OSSEOINTEGRATE AND LOSS OF OSSEOINTEGRATION (IMPLANT MOBILITY) IS IDENTIFIED AS AN ADVERSE REACTION AND IDENTIFIED IN THE LIST OF WARNINGS IN ALL END-OSSEOUS DENTAL IMPLANT LABELING. THE SPECIFIC CAUSE FOR A PARTICULAR COMPLAINT IS OFTEN NOT READILY IDENTIFIED AS THERE ARE VARIOUS FACTORS THAT CONTRIBUTE TO THE RISK OF IMPLANT FAILURE. THESE INCLUDE SYSTEMIC MEDICAL CONDITIONS (UNCONTROLLED DIABETES MELLITUS, AIDS, OSTEOPOROSIS), POOR BONE QUALITY AND QUANTITY OF BONE IN WHICH THE IMPLANT IS IMPLANTED, MEDICATIONS (CORTICOSTEROIDS, BISPHOSPHONATES), HARMFUL HABITS TO HEALING (SMOKING), SECONDARY INFECTION AND/OR SURGICAL TRAUMA, UNEXPERIENCED CLINICIAN, IMPROPER SURGICAL TECHNIQUE, OR MOBILITY OF THE IMPLANT LEADS TO ITS REMOVAL OR REPLACEMENT, HENCE DENTAL IMPLANT FAILURE. IN ADDITION, A RATE OF IMPLANT FAILURE THAT DOES NOT AFFECT THE PRODUCTS' RISK ASSESSMENT DOES NOT REQUIRE INVESTIGATION AS IT IS A WELL-KNOWN FAILURE MODE THAT HAS BEEN ADEQUATELY STUDIED IN THE PAST.

Description of Event or Problem · 0

FAILED TO OSSEOINTEGRATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
963224 DYMIC DYNAMIC IMPLANT SP 4.2X8 DZE PALTOP ADVANCED DENTAL SOLUTIONS INC. 21-70006 WO-016719 D76821700060

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention